Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Jenavalve Technology Inc. currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 2 distinct examiners, which suggests that the company is managing multiple independent review processes simultaneously. The workload is also spread across a matching number of distinct art units, indicating that the patent applications cover different technical sub-sectors within the medical device field.
STEWART, ALVIN J is the busiest examiner for the portfolio, currently holding 1 pending action. Since this busiest examiner pending count of 1 is lower than the total of 2 pending office actions, the prosecution is divided between the distinct examiners. This lack of concentration means that the company's patent outcomes are not determined by a single individual. Practitioners must adapt to the different styles of the distinct examiners involved to ensure consistent results across the portfolio. The presence of multiple distinct art units further suggests a need for specialized technical arguments tailored to each unit's specific standards.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEWART, ALVIN J | 1 | 82.1% | +0.7% |
| GANESAN, SUBA | 1 | 73.8% | +13.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18518253 | CATHETER SYSTEM FOR SEQUENTIAL DEPLOYMENT OF AN EXPANDABLE IMPLANT | STEWART, ALVIN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17505287 | STENT FOR THE POSITIONING AND ANCHORING OF A VALVULAR PROSTHESIS IN AN IMPLANTATION SITE IN THE HEART OF A PATIENT | GANESAN, SUBA | 45d overdue |
| Art Unit | Apps |
|---|---|
| 3799 | 1 |
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18518253 | CATHETER SYSTEM FOR SEQUENTIAL DEPLOYMENT OF AN EXPANDABLE IMPLANT | STEWART, ALVIN J | 3799 | §102§103§112 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 17505287 | STENT FOR THE POSITIONING AND ANCHORING OF A VALVULAR PROSTHESIS IN AN IMPLANTATION SITE IN THE HEART OF A PATIENT | GANESAN, SUBA | 3774 | §103 | Final Rejection | 45d overdue | Pending | Oct 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial